Variant "GBA2:n.35766561C>T"
Search result: 1 record
Variant information
Gene:
Variant:
GBA2:n.35766561C>T 
Genomic location:
chr9:35766561(hg19) 
HGVS:
SO Term RefSeq
MSMP-NPR2:n.35766561C>T
dbSNP ID:
GWAS trait:
Modifier statisitcs
Record:
Disorder:
Reference:
Effect type:
Expressivity(1)  
Modifier effect:
Altered glucosylceramide(1)  
Detail:
  • Target disease:
    Gaucher's Disease (DOID_1926)
    Effect type:
    Expressivity 
    Modifier effect:
    Altered glucosylceramide 
    Evidence:
    Study on animal models 
    Effect:
    GBA2 as a plausible modifier for GBA1 in patients with GD
    Reference:
    Title:
    Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
    Species studied:
    Human
    Abstract:
    Gaucher disease (GD) is the most common inherited lysosomal storage disorder in humans, caused by mutations in the gene encoding the lysosomal enzyme glucocerebrosidase (GBA1). GD is clinically heterogeneous and although the type of GBA1 mutation plays a role in determining the type of GD, it does not explain the clinical variability seen among patients. Cumulative evidence from recent studies suggests that GBA2 could play a role in the pathogenesis of GD and potentially interacts with GBA1.